Post by Antonio Angrisani

Truly happy and proud to share that our Policy Review, “Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy" has just been published in The Lancet Oncology! The paper presents a unique perspective from the ESTRO Focus group on how radiotherapy can enhance the activity of novel anticancer drugs, providing concrete examples of radiotherapy–drug combinations and their diverse potential in terms of efficacy. It ultimately encourages a fundamental shift in the drug development process. It has been a privilege to contribute to this collaborative effort, and I’m grateful to all co-authors and FG members for their brilliant input, stimulating discussions, and teamwork. Special thanks to Prof. Dr Dirk De Ruysscher for his leadership and guidance throughout this work. You can easily find the article available for a short time for free download: https://lnkd.in/e2Vq95QH Looking forward to the conversations this work will hopefully spark! Azadeh Abravan Youlia Kirova Carlotta Becherini Sergi Benavente Luis Castelo-Branco Anthony Chalmers Sebastian M. Christ eric deutsch Andrea R. Filippi Lizza Hendriks Tim Illidge PD Dr. med. Andreas Rimner Fernanda Herrera Members of the European Society for Radiotherapy and Oncology (ESTRO) Focus Group of systemic #therapies and #radiotherapy #drugdevelopment #radiation #oncology